Skip to content

INGENIO MRI/ FINELINE II ImageReadyTM pacing system data collection in patients undergoing Magnetic Resonance Imaging

INGENIO MRI/ FINELINE II ImageReadyTM pacing system data collection in patients undergoing Magnetic Resonance Imaging - INFINITE MRI

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38918
Enrollment
20
Registered
2013-05-23
Start date
2013-06-17
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Magnetic Resonance Imaging (MRI) Cardiac Rhythm disease

Interventions

None listed

Sponsors

Boston Scientific Cooperation International
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law • Patients already implanted with ImageReady* MR Conditional Pacing System, including INGENIO* MRI or ADVANTIO* MRI pulse generators with FINELINE* II Sterox endocardial lead(s), according to standard medical guidelines for pacemaker implantation. • Willing and capable of participation to the procedures indicated in the protocol.

Exclusion criteria

Exclusion criteria: • Patients implanted with pulse generator location outside of left or right pectoral regions • Patients implanted with other cardiac-related implanted devices or accessories other than the ImageReadyTM MR Conditional Pacing System • abandoned leads or pulse generators (PG) • evidence of a fractured lead or compromised PG-lead system integrity • Low life expectancy (

Design outcomes

Primary

MeasureTime frame
The study will collect standard device measurement through device interrogation done before MRI scan, post an MRI scan and at a 30 day follow up. Device measurement will include the following lead: amplitude, threshold and impedance. The study has no primary endpoint and is not hypothesis driven.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)